Retail buzz around major pharmaceutical stocks jumped Thursday, with sentiment turning bullish across most major drugmakers, ...

Both Eli Lilly LLY and Merck MRK are major players in the U.S. pharmaceutical industry, developing and commercializing therapies across oncology, immunology, and diabetes and cardiovascular areas.

In letters posted on Truth Social, Trump demanded that drugmakers offer their medications at the same prices paid abroad.

President Trump urges top pharmaceutical firms to lower U.S. drug prices under his most-favored-nation drug pricing policy ...

Trump posted individual letters he sent 17 drugmakers, including Eli Lilly, GSK, Pfizer, Regeneron, Merck, Pfizer and Novo ...

U.S. President Donald Trump sent letters to the chief executives of 17 major pharmaceutical companies, urging immediate ...

In the letters, sent to Eli Lilly & Co., Novo Nordisk A/S, Pfizer Inc. and others, Trump insisted companies immediately lower ...

President Donald Trump is ratcheting up the pressure on major drugmakers to bring their US prices in line with the far lower ...

Merck KGaA is spending $85 million to get global commercialization rights to pimicotinib, a candidate for non-malignant tumors that it licensed from Abbisko Therapeutics. Eli Lilly is expanding its ...

In 17 identical letters posted to his Truth Social account, the president said companies must lower their prices or the ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.